The individual correlations between UpH and each measurement item at the baseline
| Dependent variable=UpH | r | p Value |
|---|---|---|
| Independent variable | ||
| 8-OHdG | −0.60 | <0.0001 |
| Age | −0.08 | 0.86 |
| BMI | −0.29 | 0.001 |
| WC | −0.27 | 0.002 |
| UA | −0.42 | <0.0001 |
| Gender | 0.08 | 0.78 |
| Duration | −0.10 | 0.75 |
| Glucose | −0.11 | 0.32 |
| HbA1c | −0.011 | 0.91 |
| eGFR | 0.300 | <0.0001 |
| ACR | −0.22 | 0.003 |
| SBP | −0.16 | 0.08 |
| DBP | −0.10 | 0.10 |
| Heart rate | −0.22 | 0.008 |
| TC | −0.00 | 0.91 |
| TG | −0.12 | 0.09 |
| HDL-C | 0.15 | 0.07 |
| BUN | −0.23 | 0.0001 |
| ALT | −0.21 | 0.0003 |
| AST | −0.18 | 0.0010 |
| K+ | −0.11 | 0.09 |
| Cl− | −0.22 | 0.0002 |
| Na+ | 0.04 | 0.87 |
| Na+/Cl− | −0.26 | <0.0001 |
| Plt | −0.01 | 0.89 |
| Hb | 0.03 | 0.68 |
| WCC | −0.23 | 0.0001 |
| TP | −0.07 | 0.43 |
| PWV | −0.03 | 0.54 |
| ABI | 0.01 | 0.90 |
| IMT | 0.09 | 0.35 |
| RASIs | −0.21 | 0.0001 |
| Drugs 2003 | −0.52 | <0.0001 |
| Drugs 2013 | −0.55 | <0.0001 |
| ΔDrugs | −0.36 | <0.0001 |
ΔDrugs, changes in the number of drugs taken from the baseline to the end point; 8-OHdG, 8-hydroxy-2′-deoxyguanosine; ABI, ankle brachial index; ACR, albumin–creatinine ratio; ALT, alanine aminotransferase; AST, aspartate transaminase; BMI, body mass index; BUN, blood urea nitrogen; DBP, diastolic blood pressure; Drugs 2003, the number of drugs taken at the baseline; Drugs 2013, the number of drugs taken at the end point; eGFR, estimated glomerular filtration rate; Glucose, plasma glucose concentration; Hb, hemoglobin; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; IMT, intima-media thickness; Plt, platelet; PWV, pulse wave velocity; RASIs, renin-angiotensin system inhibitors; SBP, systolic blood pressure; TC, serum total cholesterol; TG, serum triglyceride; TP, total protein; UA, uric acid; UpH, urinary pH; WC, waist circumference; WCC, white cell count.